A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease
Public ClinicalTrials.gov record NCT06088979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight weeks to TED patients who are in the active inflammatory phase of disease.
Study identification
- NCT ID
- NCT06088979
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 19, 2024 (Actual)
- Primary completion
- Sep 2026 (Estimated)
- Completion
- Sep 2027 (Estimated)
- Last update posted
- Apr 23, 2026
2024 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Catalina Eye Care - Site 840-121 | Tucson | Arizona | 85712 | — |
| Foothill Eye Institute - Site 840-116 | Pasadena | California | 91107 | — |
| University of California Davis Eye Center - Site 840-119 | Sacramento | California | 95817 | — |
| The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122 | San Francisco | California | 94115 | — |
| UC Hospital Sue Anschulz-Rodgers Eye Center - Site 840-101 | Aurora | Colorado | 80045 | — |
| Bascom Palmer Eye Institute - Site 840-115 | Miami | Florida | 33136 | — |
| Ophthalmic Consultants of Boston - Site 840-128 | Boston | Massachusetts | 02114 | — |
| Kahana Oculoplastic and Orbital Surgery - Site 840-112 | Livonia | Michigan | 48152 | — |
| Ophthalmic Plastic, Reconstructive, Orbital & Cosmetic Surgery - Site 840-123 | Las Vegas | Nevada | 89144 | — |
| Hackensack University Medical Center - Site 840-105 | Hackensack | New Jersey | 07601 | — |
| Columbia University - Site 840-125 | New York | New York | 10032 | — |
| Academy of Diabetes, Thyroid, and Endocrine - Site 840-129 | El Paso | Texas | 79935 | — |
| DCT Fort Worth Research Center - Site 840-133 | Fort Worth | Texas | 76132 | — |
| Sun Research Institute - Site 840-120 | San Antonio | Texas | 78215 | — |
| University of West Virginia - Site 840-113 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06088979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06088979 live on ClinicalTrials.gov.